Business Wire

MD-KOOLSPAN

Share
KoolSpan Partners with SIRIN LABS to Integrate TrustCall Secure Mobile Communications Solution into SOLARIN “Super” Smartphone

KoolSpan, Inc. , a leading provider of encrypted secure voice and messaging solutions for mobile phones, today announced a partnership with SIRIN LABS , a revolutionary new entrant to the mobile technology arena. SIRIN’s state-of-the-art SOLARIN smartphone is the world’s most uncompromising and secure smart phone for the world’s most discerning and demanding clientele. It is comprised of carefully curated security technologies including TrustCall , KoolSpan’s flagship secure mobile communications solution, which offers unparalleled usability combined with the benefits of increased accessibility to end-to-end mobile encryption technology. SIRIN LABS chose TrustCall as the encryption platform of choice for the SOLARIN because it is known globally as the most robust, end-to-end secure voice and messaging solution available on today’s market.

In partnership with SIRIN LABS, KoolSpan developed a heavily customized version of TrustCall optimized for the best performance on the SOLARIN device. KoolSpan’s highly robust chip and software architecture allows SOLARIN users to protect calls and messages without degrading performance. SOLARIN users also have the ability to communicate securely with TrustCall users on other popular smartphones, including iPhone and Android devices, through Secure Comm by SIRIN LABS.

“SIRIN LABS is centered around three core values: technology, security and quality. Therefore it was paramount in the delivery of our first product, SOLARIN, to push the boundaries of each,” said Tal Cohen, CEO and co-founder, SIRIN LABS. “When it comes to privacy, KoolSpan’s TrustCall technology is the best in the world for robust, end-to-end secure voice and messaging. In partnership, we developed a heavily customized version for SOLARIN, providing the perfect combination of usability and functional security for our customers.”

TrustCall combines the strength and security of a hardware-based encryption platform with the flexibility and ease of software by utilizing the existing secure elements of mobile devices. It offers a familiar, easy to use interface with FIPS 140-2 validated, 256-bit AES encryption which lets users exchange secure calls and text messages anywhere they travel, without requiring device modifications.

“Cyberattacks and surveillance threats are rapidly multiplying on a global scale, creating an increasing demand for secure communications technology,” said Nigel Jones, CEO of KoolSpan. “Our solutions offer both consumers and enterprise users worldwide a range of flexible mobile encryption solutions to restore their trust that their calls and messages are only accessible to the initiator and intended recipient - and never left unencrypted.”

KoolSpan offers two interoperable versions of TrustCall to match organizations’ distinct requirements: TrustCall Global Service , a fully hosted, subscription-based encryption service for mobile calls and text messaging, eliminating capital and infrastructure costs; and TrustCall DIRECT , for government organizations and large enterprises looking to secure their mobile communications while maintaining complete control over their mobile communications infrastructures. TrustCall DIRECT can be deployed on-premise or in a private cloud and is compatible with mobile device management (MDM) software.

KoolSpan’s newest offerings, TrustCall DIRECT Enterprise Version 4.0 and TrustCall DIRECT Service Provider Version 4.5, are the first enterprise-grade secure mobile communications solutions designed to enable seamless integration with organizations’ existing infrastructure and service providers’ core systems. These solutions put the world-class secure communications capability of TrustCall into the hands of government and commercial organizations, providing encryption solutions that are flexible for both “on premise” as well “as a service” options.

For more information on KoolSpan’s TrustCall, please visit: https://koolspan.com/features/trustcall-encrypted-phone-calls-and-messaging/ .

About KoolSpan

KoolSpan is the leading provider of robust, cross-platform, end-to-end communication security on mobile devices. KoolSpan offers multiple encryption solutions supporting Android, iPhone and BlackBerry phones. KoolSpan’s security and privacy solutions address the growing threat of loss or theft of intellectual property, vital information and proprietary assets. Customers include government organizations and enterprises in over 60 countries worldwide. KoolSpan is FIPS 140-2 validated and has 21 issued patents with dozens more pending. KoolSpan is privately held and based in Bethesda, Md.

For more information on KoolSpan: visit www.koolspan.com , or follow KoolSpan on Twitter @KoolSpan .

About SIRIN LABS

SIRIN LABS AG is a revolutionary new entrant to the technology arena with one simple goal, to bring tomorrow to our customers, today. Backed by significant investment from some of the most respected players at the forefront of new technology, the company has been driven by a determination to deliver uncompromising connected devices. Visit our website, https://www.sirinlabs.com/ or YouTube channel. Follow SIRIN LABS on Instagram , Facebook and LinkedIn .

Contact:

W2 Communications
Dex Polizzi, 703-877-8106
dex@w2comm.com

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

CCM Biosciences Announces Presentation of Data on its First-In-Class AML Drug Program at ASCO 202520.5.2025 22:30:00 CEST | Press release

Company’s AML drug program is focused on both newly diagnosed and relapsed/refractory FLT3-positive AML, overcoming major forms of resistance to FDA-approved FLT3 inhibitors, and outperforms other investigational inhibitors in a wide range of drug resistance models. CCM Biosciences, a diversified pharmaceutical discovery and development company, today announced the upcoming presentation of its next-generation FLT3 inhibitor drug program for acute myeloid leukemia (AML) at the 2025 Annual Conference of the American Society of Clinical Oncology (ASCO), taking place May 30 to June 3 in Chicago. Acute Myeloid Leukemia (AML) is the most severe form of leukemia with few treatment options, and a malignancy frequently driven by mutations in the FMS-like tyrosine kinase 3 (FLT3) gene. The FLT3 internal tandem duplication (ITD) and tyrosine kinase domain (TKD) mutations, particularly D835 and F691, appear in approximately 30% of AML patients, often leading to poor prognosis and resistance to exi

IonQ Partners with Sweden’s Einride to Develop Quantum Supply Chain and Quantum-Enhanced Logistics for Autonomous Driving Solutions20.5.2025 22:05:00 CEST | Press release

IonQ and Einride will collaborate to develop quantum solutions for fleet routing, logistics optimization, and supply chain solutionsIonQ’s investment will grow its European presence and reinforce commitment to building a quantum economy in Sweden and the European market IonQ (NYSE: IONQ), a leading commercial quantum computing and networking company, today announced an investment partnership with Einride, a leading global freight mobility company that provides digital, electric, and autonomous technology to explore how quantum computing can drive the next generation of fleet optimization and logistics. Together, IonQ and Einride will develop quantum applications that address large-scale routing and scheduling problems that have traditionally challenged classical computing. By combining IonQ’s advanced quantum systems with Einride’s expertise in autonomous fleet logistics, the two companies will work to unlock new levels of efficiency, reliability, and sustainability for the global frei

CCM Biosciences Announces Presentation of Data on its First-In-Class NSCLC Drug Program at ASCO 202520.5.2025 21:26:00 CEST | Press release

Company’s NSCLC drug program is focused on overcoming both mutational and non-mutational resistance to 3rd-generation EGFR inhibitors and outperforms other investigational 4th-generation inhibitors in a wide range of drug resistance models. CCM Biosciences, a diversified pharmaceutical discovery and development company, today announced the upcoming presentation of its 4th-generation EGFR inhibitor drug program for non-small cell lung cancer (NSCLC) at the 2025 Annual Conference of the American Society of Clinical Oncology (ASCO), taking place May 30 to June 3 in Chicago. NSCLC, which accounts for 80% of lung cancer, is the most common cause of cancer death worldwide. Epidermal growth factor receptor (EGFR)-activating mutations (Del19 or L858R) are major oncogenic drivers of NSCLC. EGFR-positive NSCLC accounts for approximately 30% of all diagnosed cases of NSCLC (a similar market size to PD-L1-positive NSCLC, which is addressed by the world’s top-selling drug, Keytruda®). The current s

NielsenIQ's Chief Technology Officer Mohit Kapoor Named Executive of the Year at Global Tech & AI Awards for Leading NIQ’s AI-Driven Tech Transformation20.5.2025 21:24:00 CEST | Press release

NielsenIQ (NIQ) is proud to announce that Mohit Kapoor, Chief Technology Officer, was named Executive of the Year at the inaugural Global Tech & AI Awards. This honor recognizes Mohit's exceptional leadership and visionary contributions to the tech industry, particularly in the realm of AI-powered consumer intelligence. "I am deeply honored to receive the Executive of the Year award at the Global Tech & AI Awards. This recognition is a testament to the incredible work and dedication of the entire NielsenIQ team,” said Mohit Kapoor, Chief Technology Officer, NIQ. “Together, we have redefined consumer and retail intelligence, leveraging AI to deliver unparalleled insights and drive meaningful change in the industry." Under Mohit's leadership, NIQ has adopted an AI-powered approach to its ambitious digital transformation which included a $400 million technology investment and the migration of its global client base onto Discover– a unified, cloud-based platform that seamlessly integrates

Strategic Partnership Between the Government of Morocco and TAQA Morocco, Nareva, ONEE and the Mohammed VI Investment Fund to Develop Key Power and Water Infrastructures in the Kingdom of Morocco20.5.2025 21:08:00 CEST | Press release

As part of the implementation of the commitments made in the joint declaration between His Majesty King Mohammed VI, may God Assist Him, and His Highness Sheikh Mohamed bin Zayed Al Nahyan, TAQA Morocco, in partnership with Nareva and the Mohammed VI Fund for Investment, has signed three memorandums of understanding and related development agreements with the Government of Morocco and ONEE. These agreements cover the development of structuring projects in the power, water and renewable energy sectors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250520313620/en/ Strategic Partnership Between the Government of Morocco and TAQA Morocco, Nareva, ONEE and the Mohammed VI Investment Fund to Develop Key Power and Water Infrastructures in the Kingdom of Morocco (Photo: AETOSWire) The program aims to strengthen the Kingdom's water and energy sovereignty through the development of flexible natural gas-based power generation capacit

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye